Bergan T
Antimicrob Agents Chemother. 1978 Jun;13(6):971-4. doi: 10.1128/AAC.13.6.971.
Bacampicillin is a new oral prodrug which is rapidly converted to ampicillin during absorption from the gastrointestinal tract. High serum peaks of ampicillin are obtained. Bacampicillin orally was compared pharmacokinetically with parenteral ampicillin (intravenously and intramuscularly). A cross-over study on healthy volunteers showed that ampicillin concentrations after equimolar doses of bacampicillin orally and ampicillin intramuscularly were of the same order. The mean of the individual peak values (regardless of time of occurrence) after a dose of 800 mg of bacampicillin was 13.1 +/- 3.8 mug/ml. Absorption rates of the two doses were similar, as were their distribution volumes (approximately 25% of the body weight). Bioavailability was 87% for bacampicillin, compared to 71% for ampicillin.
巴卡西林是一种新型口服前体药物,在从胃肠道吸收过程中会迅速转化为氨苄西林,可获得较高的氨苄西林血清峰值。对巴卡西林口服给药与胃肠外途径给药(静脉注射和肌肉注射)的氨苄西林进行了药代动力学比较。一项针对健康志愿者的交叉研究表明,口服等摩尔剂量的巴卡西林和肌肉注射氨苄西林后的氨苄西林浓度处于同一水平。服用800毫克巴卡西林后,个体峰值的平均值(无论出现时间)为13.1±3.8微克/毫升。两种剂量的吸收率相似,分布容积也相似(约占体重的25%)。巴卡西林的生物利用度为87%,而氨苄西林为71%。